Johnson & Johnson to Participate in 37^th Annual JP Morgan Health Care Conference

New Brunswick, NJ (Dec. 24, 2018) -- Johnson & Johnson (NYSE: JNJ) will participate in the 37^th Annual JP Morgan Health Care Conference on Monday, Jan. 7^th, at the Westin St. Francis in San Francisco. Joseph J. Wolk, Executive Vice President and Chief Financial Officer; Jennifer Taubert, Executive Vice President, Pharmaceuticals and Ashley McEvoy, Executive Vice President, Medical Devices, will represent the Company in a session scheduled at 2:30 p.m. (Pacific Time) / 5:30 p.m. (Eastern Time). Alex Gorsky, Chairman and Chief Executive Officer, will accompany the team for a subsequent Question & Answer session scheduled for 3:00 p.m. (Pacific Time) / 6:00 p.m. (Eastern Time).

A webcast for both events will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A recording of the webcasts and podcasts will be available approximately two hours after each event.

###